CF Foundation | CF Drug Development Pipeline and Clinical Trial Process скачать в хорошем качестве

CF Foundation | CF Drug Development Pipeline and Clinical Trial Process

This town hall is intended to educate the cystic fibrosis community about the phases of clinical trials and the cystic fibrosis Drug Development Pipeline. This is the third in a four-part series of regional cystic fibrosis research town halls to familiarize the CF community with the clinical trial process, how clinical researchers protect participants’ safety and privacy, new areas of CF research, and how people with CF can get involved. The town hall was hosted by the Southeast Research Cooperative, which is made up of several research centers throughout the South that are committed to assisting with referrals for clinical trials and promotion of CF research throughout the region. Originally recorded September 19, 2023. 00:00 | CF Drug Development Pipeline and Clinical Trial Process 04:54 | What do clinical trials study? 06:01 | Why are clinical trials necessary? 06:51 | What are the phases of research before clinical trials start? 07:54 | What happens during the four phases of clinical trials? 11:28 | How long does each clinical trial phase last? 15:21 | What is the CF Drug Development Pipeline? 19:41 | What are the six categories on the Drug Development Pipeline? 21:00 | What are anti-infectives? 23:49 | What types of bugs are being focused on in the area of anti-infectives? 25:42 | What are the general eligibility criteria for anti-infective clinical trials? 29:19 | What are anti-inflammatories? 32:53 | What is the focus of anti-inflammatory research? 35:15 | An explanation of the nutrition-gastrointestinal (GI) category (plus endocrinology) 36:11 | What is the bionic pancreas? 39:19 | Information on ongoing observational studies 41:42 | What search filters can you use on the Clinical Trial Finder? 44:08 | If a person with CF is doing well on a modulator, what should motivate them to participate in new research? 49:04 | If a person with CF participates in an early phase clinical trial, can they participate in later phases of the same trial? 52:14 | What should motivate people with CF to participate in observational studies? Should they participate in observational studies if they may or may not be able to participate in therapeutic trials happening at the same time? 58:58 | How are drugs selected to go into the pipeline?